Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Sherman

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Oral Oncology|July 11, 2020
Past, present and future of proton therapy for head and neck cancerXingzhe Li, Anna Lee, Marc A Cohen, et al.
Lancet (London, England)|May 14, 2026
Proton versus photon therapy for oropharyngeal cancerSean M McBride, Nadeem Riaz, Eric J Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2025
Optimizing Outcomes After Transoral Robotic Surgery for Oropharyngeal Carcinoma: Reflections on the ASCO GuidelineAmir H Safavi, Nadeem Riaz, Eric J Sherman, et al.
Thyroid : Official Journal of the American Thyroid Association|April 19, 2012
Hemorrhagic pseudoaneurysm in a patient receiving aflibercept for metastatic thyroid cancerShrujal S Baxi, Eric J Sherman, Katherine W Kelly, et al.
Head & Neck|May 25, 2024
Effect of time-of-day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trialJames R Janopaul-Naylor, Lillian Boe, Yao Yu, et al.
Head & Neck|December 24, 2014
Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximabShrujal S Baxi, Caitriona O'Neill, Eric J Sherman, et al.
Head & Neck|October 1, 2017
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancerLara A Dunn, Matthew G Fury, Eric J Sherman, et al.
Journal of Medical Internet Research|October 15, 2024
Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical TrialsTony K W Hung, Gilad J Kuperman, Eric J Sherman, et al.
International Journal of Cancer|January 26, 2018
Head and neck cancers associated with exposure to the September 11, 2001 World Trade Center terrorist attacksJonathan E Leeman, Sean M McBride, Daniel Spielsinger, et al.
Cell Reports. Medicine|December 2, 2025
Optimal post-treatment surveillance strategy for human papillomavirus-positive oropharyngeal cancerCaineng Cao, Eric J Sherman, Nadeem Riaz, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Oral Oncology|July 11, 2020
Past, present and future of proton therapy for head and neck cancerXingzhe Li, Anna Lee, Marc A Cohen, et al.
Lancet (London, England)|May 14, 2026
Proton versus photon therapy for oropharyngeal cancerSean M McBride, Nadeem Riaz, Eric J Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2025
Optimizing Outcomes After Transoral Robotic Surgery for Oropharyngeal Carcinoma: Reflections on the ASCO GuidelineAmir H Safavi, Nadeem Riaz, Eric J Sherman, et al.
Thyroid : Official Journal of the American Thyroid Association|April 19, 2012
Hemorrhagic pseudoaneurysm in a patient receiving aflibercept for metastatic thyroid cancerShrujal S Baxi, Eric J Sherman, Katherine W Kelly, et al.
Head & Neck|May 25, 2024
Effect of time-of-day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trialJames R Janopaul-Naylor, Lillian Boe, Yao Yu, et al.
Head & Neck|December 24, 2014
Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximabShrujal S Baxi, Caitriona O'Neill, Eric J Sherman, et al.
Head & Neck|October 1, 2017
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancerLara A Dunn, Matthew G Fury, Eric J Sherman, et al.
Journal of Medical Internet Research|October 15, 2024
Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical TrialsTony K W Hung, Gilad J Kuperman, Eric J Sherman, et al.
International Journal of Cancer|January 26, 2018
Head and neck cancers associated with exposure to the September 11, 2001 World Trade Center terrorist attacksJonathan E Leeman, Sean M McBride, Daniel Spielsinger, et al.
Cell Reports. Medicine|December 2, 2025
Optimal post-treatment surveillance strategy for human papillomavirus-positive oropharyngeal cancerCaineng Cao, Eric J Sherman, Nadeem Riaz, et al.
Pageof 12